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ABSTRACT	OF	THE	DISSERTATION	
Fabrication of Nanotopographic Ophthalmic Device 
By Junming Cai (Jimmy) 
Master of Science in Biomedical Engineering 
 University of California, Irvine, 2019 
Professor Albert F. Yee, Chair 	
 Corneal	disease	is	the	second	most	prevalent	cause	of	blindness	in	the	world.	Keratoplasty	or	corneal	transplant	is	available	as	the	last	treatment	resort	and	extended	drug	delivery	following	the	procedure	are	preferred	to	be	delivered	by	a	drug	eluting	contact	lens.	Patients	using	either	device	in	the	wounded	eye	are	prone	to	microbial	infection	that	could	complicate	the	outcome	of	the	sight	recovery.	Thus,	nanotopography,	a	physical	surface	modification	studied	to	have	potential	antimicrobial	effect	and	wound	healing	promotion,	is	considered	to	be	integrated	in	novel	design	of	both	devices.	Due	to	the	spherical	nature	of	the	eye,	conventional	nanotechnology	could	not	produce	such	surface,	or	requires	heavy	cost	and	resources.		 In	this	thesis,	I	:	1)	improve	a	nanopatterning	technique	for	spherical	surface	and	apply	it	on	a	novel	cornea	device,	2)	validate	its	biological	responses	in	vivo,	3)	apply	the	patterning	technique	for	a	contact	lens	design	with	a	new	class	of	material,	4)	analyze	the	economic	and	commercial	benefits	of	both	device	in	current	ophthalmic	market.	This	thesis	consists	universal	protocol	for	adaptive	patterning	methods	on	various	material	platform	and	outline	validation	method	for	future	regulatory	works.	This	thesis	shall	set	the	foundation	for	a	medical	device	startups	that	could	restore	sights	for	millions	around	the	world.									
		 ix 
								
		 1 
Chapter	1.	Introduction	
1.1 Cornea Anatomy and Function 
 Eye is an essential organ in human’s sensory system. Estimated approximately 80% of 
our perceived information comes from vision. Eye is also a highly complex and intricate system. 
The major structures of the eye are illustrated. The wall of the eye consists of three concentric 
layers: an outer layer, a middle layer, and an inner layer. The outer layer, which is fibrous, 
includes the cornea, corneal epithelium, conjunctiva, and sclera. The middle layer, which is 
vascular, includes the iris and the choroid. The inner layer, which is neural, contains the retina.1 
Healthy eye provides a precise and agile control of focal system that transmit and transduce light 
signals to our central nervous system. 
Cornea, the clear, dome-shaped front portion of the eye, is responsible to focus light from the 
environment onto the back side of the eye where retina converts light signals into neural signals 
for perception formation. The cornea is comprised of five layers: the outermost corneal 
epithelium, which consists of superficial epithelial cells, central superbasal epithelial cells and an 
inner single layer of basal epithelial cells; the Bowman's layer; the corneal stroma which is 
populated by keratocytes; the Descemet's membrane and the inner corneal endothelium, which is 
a monolayer of neural crest-derived endothelial cells. 2 
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Figure 1.1. Anatomy of a Human Eye (top) and Cellular Hierarchy of Cornea (bottom)2 
1.2 Biomechanical and Optical Property of the Cornea 
 Cornea’s laminar layering provides high optical transparency and anisotropic 
elastic property.  Due to orderly arrangement of collagen fibrils in the cornea, it is highly 
transparent with transmission above 95% in the spectral range of 400-900 nm. The refractive 
index of the cornea is n≈1.3765±0.0005. The remaining components between cornea and the 
retina has a range of refractive index from1.335 to 1.42. 3However, regeneration of the cornea 
from heavy trauma is short of enough guidance. The less organized scarring process usually lead 
to blurry vision and would worsen overtime due to the abnormality in its mechanical 
performance. 4 
  
Table 1: Reflective index of used materials 
Material PMMA Polyurethane (Texin) Chitosan 
Refractive Index (n) 1.481-1.499 1.51 5 1.332-1.336 6 
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1.3 Corneal Conditions Affecting Patient’s Visions 
The cornea could be affected by a wide range of conditions that could lead to visual 
impairment. The external source of the conditions could be physical, chemical or biological. 
Physical injury is induced by foreign objects with abrupt forces that starches or even penetrates 
into the eye. Corrosive chemicals exposure, such as strong acid and base splash, is a primary 
example of chemical source. Also, commonly, pathogens including bacteria, viruses, fungi and 
parasites, could infect corneal tissue and cause inflammatory condition medically called keratitis. 
2 Another major class of conditions that affect patient’s visual is corneal dystrophies. 
Keratoconus and Fuch’s Dystrophy are two of the more common types within the class. Unlike 
the previous mentioned, corneal dystrophies are usually inherited through family history, and 
generally progress relatively slowly. Thus, they tend to be mostly diagnosed in professional 
settings.  
1.4 Overview of Treatment Options 
 Treatments to recover vision for cornea related diseases are available, and have 
developed progressively in recent years, thanks to various technological advancements including 
the integrative use of laser in ophthalmology. Phototherapeutic keratectomy (PTK) is the 
technique that utilize laser or UV light source to reform the cornea into a healthier stage, and 
usually applied to delay the need of more invasive procedures. In severe cases, however, surgical 
corneal grafting or corneal replacement is required to restore better visual outcome. Corneal 
transplant, medically termed keratoplasty, is the more invasive group of options to rescue 
patient’s eyesight. It is typically performed under anesthesia and outpatient in designated eye 
centers or ophthalmic clinics. A portion of or the whole cornea is removed and replaced by an 
external healthy counterpart, and anchored by surgical sutures by trained ophthalmologists, 
shown in the illustration below. (Figure 1.2) Based on the replacement, keratoplasty could be 
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further sectioned into partial thickness transplant consisting of anterior lamellar keratoplasty, 
endothelial lamellar keratoplasty, and full thickness transplant or penetrating keratoplasty.   
 
Figure 1.2. Brief Procedure Illustration of Keratoplasty 7 
 
Performing keratoplasty relies on not only skilled surgeons, but also sourcing visually 
functional cornea tissue or corneal device. Corneas, as the most transplanted tissue worldwide, 
are consumed more than 47,000 times in the United States alone in 2014. The majority of these 
transplants uses donor tissues, with a small fraction (~1%) taken by artificial cornea replacement.  
1.5 Unmet Need of Tissue Based Replacement 
Nearly five million people in the world are affected by corneal blindness, which affects 
the front part of the eye crucial for light passage and clear vision. Current treatment options are 
limited to donor corneas and early artificial devices such as the Boston Keratoprosthesis (KPro).  
Of the 12.7 million people around the world waitlisted for donor this life-changing treatment, 
only 400 patients will receive artificial corneas and 185,000 will receive donor corneas each 
year. The 1-2% of patients who regain their sight through currently available prosthetic and 
donor corneas experience high complication rates.  Donor corneas have a ten-year rejection rate 
of approximately 40%, and the KPro device has been recorded to have bacterial infection rates as 
high as 13%. 8  These numbers are currently mitigated by a lifetime regimen of daily 
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antimicrobial eyedrops and immune-suppressive prescriptions; however, such measures fail to 
alleviate the risks for noncompliant patients. Despite medical procedures exist to reverse poor 
vision for patients in need, contrasting gap of global demand and supply of such tissue 
replacement is urgently calling for innovation. 
1.6 A Brief Economic and Societal Case for Corneal Diseases Treatment 
Optimal vision impacts directly on every stage of human development as well as social 
productivity.  A CDC study estimated that the United States’ expenditure on major visual 
disorders of $35.4 billion comprised of $16.2 billion in direct medical costs, $11.1 billion in 
other direct costs, and $8 billion in productivity losses, in 2004. Annually, the federal 
government and state Medicaid agencies pay at least $13.7 billion of these costs.9  
Besides the immediate and direct constraining effect on the economics, visual disease epidemics 
could further toll the patients and the society beyond the medical bills. Blindness, the loss of 
vision, one of the most devastating deuteriations of vision, impacts estimated 36 million people 
worldwide and projected to impact more than 100 million people by 2050. It accompanied by 
current 200 million cases of moderately or severely vision impaired with the predicted 
population exploding into 600 million by 2050.10 In the EU alone, for example, these conditions 
result in the combined loss of productivity priced from €25.83-56.52 billion annually. 11 
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Figure 1.3. Global Trend and Predictions of Numbers of People Who Are Blind or Moderately and Severely Vision 
Imparied from 1990-2050 10  
1.7 Status Quo: Medical Devices that interface with cornea 	 a.	Boston	Keratoprothesis	
The current Boston Keraoprothesis could compose of a rigid PMMA front plate as the 
support of a donor corenal graft, a fenestrated titanium backing, titanium locking ring and a front 
plate locking stem. Together with harvested corneal tissue, the device is assembled on surgical 
table and sutured into patient’s eye. (Fig. 1.4) 
 
Figure 1.4 Schematics of the Assembly of the Boston K-Pro (Left) and Implanted Boston K-Pro in Patient (Right) 
		 7 
Indication and Complications: 
 Keratoprosthetics have been considered to be the last resort of surgical intervention for 
corneal-blind patients when ophthalmologist compounds the treatment decision factors including 
cost, visual outcome improvement and invasiveness. The current Boston KPro indication has 
primarily been patients with failed penetrative keratoprosthesis, aniridia, and acute ocular trauma 
such as chemical burns, herpes keratitis, corneal dystrophies, and Steven Johnson Syndrome. 2,11 
On top of diagnosis, dry eye syndromes would also impose limitation for deploying 
keratoprothesis, because the lack of abundant tear film will constrain the device efficacy and 
post-op recovery. Such sub-optimal implant could lead to surrounding tissue melts, extrusion of 
device, endophthalmitis, and even the loss of operated eye.  
 The status quo Boston Keratoprothesis sets some ground work in addressing the corneal 
replacement conditions. It has clinical track records from some of the implants functioning for 
more than 10 years inside a patient, proven that device’s biocompatibility and mechanical 
durability has to be suitable for the dynamic environment of the eye. Optically, its transparency 
is comparable to natural healthy corneal tissue, when no complications occur.  
 However, regrettably, the Boston KPro only has these ideal outcomes when all odds are 
in favor to the patients. High variability of the visual acuity, lack of personal adaptability, sizable 
rejection rate stemming from its susceptibility to pathogens, are a few of the drawbacks of 
Boston KPro that demands new innovation to catch up and resolve. Only when those issues are 
mitigated will artificial corneal replacement become clinically, economically and societally 
favorable. b.	Contact	Lens	
Need for Contact Lens/Risk of microbial keratitis  
		 8 
 Contact lens is an eyecare accessary medical device reside on top of the tear film above 
the cornea, which provide vision aids or other ophthalmic therapeutics, or occasionally for 
cosmetic purposes. It composes of a wide range of materials, primarily polymeric base. It could 
be categories generally into, soft hydrogel lens, hard contact lens, and gas permeable silicone 
lens. By replacement variation, it could be sorted into, daily, weekly and monthly disposables. 
By acquisition method, some could be purchased over the counter while some equipped with 
customized visual correction or therapeutic function will require prescriptions.2  
 
Status Quo for Contact Lens 
 Contact lens is the second most popular medical devices in the United States, with 45 
million users wearing them to correct sights, improving people’s quality of life and productivity 
seamlessly.11  With a large range of product selections for different purposes, and relatively 
superficial consumer education related their risks and proper caring habits, contact lens has 
looming risks of eye infections including microbial keratitis that could undercut their benefits.13 
Infections induced by improper care could contribute to blindness at a startling rate of 1 out of 
500 contact lens users, causing approximately 1 million hospital visits and directly costing the 
US healthcare system in estimate $175 million annually. 14,15Even when contact lens related 
infections have not gotten as grave as blindness, the array of symptoms covering from redness 
and discomfort of the eye to involuntary tearing and discharge with blurry vision, still has severe 
consequences to patients-in-need.  
What does contact lens demands? 
 New and existing products with additional layers of eyecare accessories have been 
introduced by companies to curtail the infection prospects. The user’s awareness has also been 
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growing under the help of corporations, government agency and public health advocacies. Even 
so, contact lens are still plagued by the invasion of pathogens. Therefore, eradicating the 
breeding ground for the pathogens poses highly effective preventive value medically and 
economically. On top of lens’ basic requirement to be optically transparent, mechanically 
durable under delicate handling, and high oxygen permeability to sustain cornea’s health, a novel 
solution shall also concentrate on providing sustained preventative measures against infectious 
agents.  
Chapter 2: Improving Fabrication of Artificial Cornea Device 
 In this chapter, we will introduce our first-generation cornea device, in its fabrication 
details, material, and design. It will be followed up by improvements on each of the three 
aforementioned segment and the realization of the second-generation cornea implant.  
2.1 Artificial Cornea Design 
 
Figure 2.1 Solidworks renderings of final device design. Diameters and thicknesses of central optic zone and skirt are indicated, 
as are diameter and placement of suture holes. 15 
Previously, artificial cornea device is designed with a two-step spherical lens shape is 
decorated with suture holes on the periphery.16 The radius of curvature is set to be 780 mm, 
similar to human’s average anatomical value.17 The protruded central optical region raises 0.3 
		 10 
mm above the peripheral surface. This elevation is intended to create a physical contact barrier to 
inhibit scarring tissue to overgrow onto the primary light path, giving the device better 
consistency on the recovered visual clarity after implantation. The skirt of the implant is 
designed to be 0.2 mm thick, to minimize the difficulty for the ophthalmologist to create a tissue 
pocket and to fit the device into the pocket. This could be beneficial for recovery because less 
incision could accelerate the healing timeline. The separation of the two spherical surfaces is 
setup to provide a platform to implement two different type of nanotopography, that could 
provide different biological effect to surrounding environment, in the fabrication process. The 
suture holes dimension is consistent with the suture diameters and adjusted to maximize the 
comfort of the surgeon’s operation.  
 Some future flexibility on the design are envisioned to adopt further on manufacturability 
and functionality. First, radius of curvatures on the front and the back side could both vary to 
endorse optical power for patients in need of vision correction. Second, number of Suture holes 
could be increased if higher oxygen permeability is desired.  
2.2 Advantages of nanotopography 
 Topography, the surface texture, of the material is one of the biophysical cues that could 
potentially influence its interfacing biological’s cellular response. Nanopillar, inspired by natural 
insect wings’ surface, has been studied for its antibacterial and antifungal property. 17-19 
Nanolines are more often observed to have an influence on mammalian cells guidance and 
alignment.20 Matching nanopattern’s functionality accordingly onto regions or segments in the 
tissue could achieve spatial control of the device neighboring surrounding and optimize the 
implant outcome. Using nanopatterns instead of other chemical or biological cues is advantages 
in several fronts. First, surface modification is passive and physical. Second, surface 
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modification is more sustainable than chemical cues that could be consumed or degraded in the 
long terms. Thirdly, Surface modification could induce desirable effect in a shorter and more 
precise range, preventing unwanted off-targeting effect in a global scale.  
2.3 Fabrication advancement 
Traditionally, similar to prescribed hard contact lens, the artificial cornea design is 
realized on initially PMMA using semi-automated CNC diamond-tip lathe. In brief, the design 
space is carried out in the 4 following steps: Step 1: carve out front and back curvature and 
polish down to thickness; Step 2: controlled frontal cut to accentuate central optics platform; 
Step 3: Optical polish to achieve clarity; Step 4: Fenestration or controlled drilling of suture 
holes 
The primary reason to obey the described order to reduce materials to shape is with 
regards to potential skirt fracture during thinning.  Power tool requires high shear stress on the 
skirt of the device during the thinning process and accompanied by the significant reduction of 
the material thickness, relatively brittle PMMA could fail in bulk through fracture instead. Thus, 
machining skirt with lathing has its reproducible limit down to 0.2 mm thick, although 
physicians prefer thinner (~150 micron) for easier insertion during procedure.  
In the future, to further reduce cost, volume of production and reproducibility, injection 
molding would be more preferable for prototyping than semi-automated machining. 
2.4 Nanopatterning Advancement  
2.3.1 Reversal Imprinting for nanotopography onlaying 
With the adaptation of previous work by Dickson et al., nanopatterns are transferred to 
the cornea lens. In brief, prepared and filtered 5 wt% medical grade Poly (methyl methacrylate) 
(PMMA) (>1MDa) toluene solution are spincoat cast on a PDMS nanomold replicated from a 
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nickel or silicon master, at 600 RPM for 45 seconds. The film is annealed on the hot plate at 100 
°C for 1 hr.16 
The nanostructure film is then pressed against the cornea lens in a 3-part assembly, under 
3 MPa in the Tetrahedron pneumatic press, at 105 °C for 10 minutes and actively cooled down to 
room temperature for 10 minutes before detachment from the PDMS mold. 
 
Figure 2.2 Adapted reversal nanoimprint lithography (r-NIL) scheme and sample holding devices. (a) Scheme of 
adapted r-NIL for application of PMMA pillars to a curved PMMA surface. (b) Cut-away rendering of solidworks 
model of the holder device adapted for aligning the lens, curving the PDMS elastomer mold, and transferring the 
force from the planar top and bottom plates to the curved surfaces (c) Photograph of the custom-built holder 
assembly. 21 
 
 To accommodate the curved and complex geometry in the cornea device, an adaptive 
way to transfer nanotopography from 2D flat surface to 3D curvature is necessary. Reversal 
nanoimprint lithography is using the principle where polymer at glass transition temperature will 
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present more viscous behavior and material with the same transition temperature could flow into 
each other at the contact boundary and merge, where pre-patterned film could adhere and 
transfer onto the bulk lens design. 2.4.2	r-NIL’s	Theoretical	limits	and	practical	compromises	
Although thin film could be conformal onto geometry, a two-dimensional surface 
mathematically could not perfectly fold onto a spherical surface without deformation. According 
to Gauss's Theorema Egregium in 17th century, a sphere of radius R has constant Gaussian 
curvature which is equal to 1/R2. At the same time, a plane has zero Gaussian curvature. As a 
corollary of Theorema Egregium, a piece of paper cannot be bent onto a sphere without 
crumpling. Conversely, the surface of a sphere cannot be unfolded onto a flat plane without 
distorting the distances. If one were to step on an empty egg shell, its edges have to split in 
expansion before being flattened. Mathematically, a sphere and a plane are not isometric, even 
locally. One significant application of this theorem is in cartography: it implies that no planar 
(flat) map of Earth can be perfect, even for a portion of the Earth's surface. Thus 
every cartographic projection necessarily distorts at least some distances.” 22 Creases or 
concentrated stretching of the film could provide blind spot for pathogen to opportunistically 
reproduce and propagate. Furthermore, distortion above micron level could affect the optical 
appearance of the device, if landed at the optical path.  2.4.3	Polyurethane	Elastomer	Mold	for	Adaptive	NIL	
Adaptive NIL is an alternative nanopatterning method purposed for the curved ocular 
device fabrication. The principle is similar to NIL where patterns are pressed and formed under 
elevated temperature and pressure, enabling the polymeric substrate to flow and controllably 
deformed to acquire the mold’s pattern. The novelty of this method is to use materials that is 
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capable of carrying nanopattern at high fidelity from a traditional flat planar master, made by 
either silicon or etched metal surfaces, and onlaying patterns onto spherical surface tightly with 
the mold’s high tensile strain. Similar to a removable tattoo sticker, where tattoo artists comply 
and design patterns on flat paper but transfer them onto a thin sticker that wrap the customer’s 
body part for templating. 
  
Figure 2.3 Implementation Schematics of Adaptive NIL with Polyurethane 
  
10wt% PU in DMF Solution was prepared by measuring 1.5g PU particles and 13.5g 
DMF in fume hood and mixing in 20 mL scintillator vial. The mixture is gently heated between 
70-80 °C for 2 days. The prepared solution is then dropcast on a master mold and annealed at 80 
°C for a minimum of 30 minutes. The cast thin film mold is spray-coated with Teflon spray from 
Dupont and pressed directly on the cornea or contact lens designated patterning area, either 
single side or double sides, in the similar assembly used in reversal imprinting. The imprinting 
process will be under 3 MPa at 100 °C for 20 mins and actively cooled for another 10 minutes.  
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Figure 2.4 Nanopatterned PMMA-based lens with Adaptive NIL (left), and SEM image of the nanopattern transferred 
on the lens surface (Right) 
2.5 Material System Advances: PU 
 Polymethylmethacrylate (PMMA) is a material class approved by FDA for ocular use, 
and previously adopted by Boston Keratoprothesis. It has high optical transparency, high 
young’s modulus, intermediate glass transition temperature, and historically good 
biocompatibility in the ocular environment. However, it’s relatively inflexible and brittle 
compare to other rubbery polymers, which impose extra caution for the surgeon for handling the 
device in operation.  
Polyurethane is a widely used elastomer for commercial products. Selected variation has 
good elasticity, comparable transparency and intermediate glass transition temperature. Although 
it is not yet approved by the FDA specifically in ocular application, it’s been historically applied 
in other medical environment such as vascular grafts.23  
We utilize the manufacturing advancement mentioned and adapt the craftsmanship onto 
PU instead. For it’s less brittle and flexible, the prototype’s skirt could be further reduced. The 
thin skirt additionally enables the elimination of pre-disposition of suture holes. As demonstrated 
on the left, the skirt is thin enough for the suture needle to puncture through. The removal of the 
fenestration step simplifies the manufacturing process.  
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Furthermore, as shown on the right, the surgeon could bend (or lively described as “taco-
ing” technique) with tweezers. This potentially allows surgeons to create a smaller incision and 
applying less pressure for the device deploying, which makes the procedure less risky. The small 
wound could potentially heal faster, bettering patient’s experience after the surgery.  
 
  
 
Figure 2.5 PU-based cornea prototype is tested for bending and suturing. Implantability and Easy Maneuver were 
more preferred by surgeon. Video Credit: Dr. Marjan Farid 
Chapter 3: In-vivo Study of Artificial Cornea Implant  
3.1 Motivation 
From the previous chapter, artificial cornea could be prototyped in a laboratory setting as 
designed for in-vivo testing. Thus, in this chapter, a pilot study involving animal subjects are 
conducted, with the primary anticipation to observe the live animals’ response to the implants 
and the implants durability in practice. The study hopes to refine surgical and experimental 
protocols for a more populous cohort.  
3.2 Method and Materials 3.2.1	Surgery	and	post-op	care:	
Two artificial cornea prototypes made from polymethylmethacrylate (PMMA) with a 
central antimicrobial nanotopography onlay were implanted into the right eyes of 2 New Zealand 
white rabbits. In one rabbit, a crescent blade was used to create a plane within the stroma to place 
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the skirt of the device. In the other, the femtosecond laser was used to create a plane within the 
stroma. Slit lamp and anterior segment optical coherence tomography photos were obtained 
twice a week for the first week, then weekly over a one-month period. During the period, topical 
or subconjunctival antibiotics are given to the subjects daily. The procedures are adopted from 
current surgical practice in clinics, consulted and modified with the expertise introduced by Dr. 
Farid and her associates, and approved by UC Irvine IUCAC committee. 
 
 
Figure 3.1Workflow Schematics of the Pilot Animal Implantation 3.2.2	Method	of	Analysis:		
a. Slit Lamp 
A slit lamp is a bright field microscope with a bright light projected through a think slit 
used during an eye exam. It visualizes different structures at the front of the eye and inside the 
eye. Eye drop with fluorescein is applied during this portion of the exam to highlight the 
boundary between implant and cornea tissue.  
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b. AS-OCT 
Anterior Segment Optical Coherence Tomography (AS-OCT) takes cross-sectional 
images of the cornea and anterior segment are produced with optical backscattering of light in a 
fashion analogous to B-scan ultrasonography. Because light travels much faster than sound, the 
time delay of the returning light reflection in OCT is determined indirectly by the method of low-
coherence interferometry. Optical interferometry is used to determine the distance to reflective 
structures within the eye. The OCT uses a noncontact image acquisition method that is efficient 
and safe. 
To measure the animal’s cornea profile, a Visante OCT (Carl Zeiss Meditec, Dublin, CA) 
is operated by trained technician. The animal under general anesthesia is held up into the position 
where the eye is directly looking into the measurement window for several seconds. Both side 
profiles and cornea’s height landscape could be obtained with integrated software in post 
processing.  
c. Fixation and SEM 
To fix the enucleated samples, Margo’s solution is prepared prior to the surgery for direct 
post-op immersion of 48 hours. The solution consists of 1% formaldehyde and 1.25% 
glutaraldehyde in 1x phosphate buffer saline.24  
Serial dehydration is performed by submerging the sample in ethanol solutions with 
concentrations at room temperature. For a whole eye sample, the environment is adjusted as 
followed: for the first three days, dispose 70% ethanol solution and refresh the solution every 24 
hours, on the fourth day, increase ethanol concentration to 80% for 8-hour submersion, followed 
an overnight treatment by 90% ethanol solution. On the last day, use 100% ethanol for three 8-
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hour submersion. (In brief, 3×70 % for 24 h, 1×80 % for 8 h, 1×90 % over night, 3×100 % for 8 
h) Samples are then kept in dry enclosure afterwards.  
To prepare whole eye sample for scanning electron microscopy, whole eye is placed in 
up-right position and tightly wrapped with aluminum foil and leave the anterior segments 
exposed. The aluminum foil is placed to increase the sample’s conductivity during the SEM. The 
sample is then taped onto a standard SEM stage with double-sided carbon tapes and sputter 
coated with Leica AC200 sputter coater, in a rotational deposition mode for a coating thickness 
of 5 nm.  
d. Bacterial Swap culture 
Bacterial population at the surface and the surrounding of the implant is investigated 
through culturing eye swabs before the enucleation of the animal. Sterile cotton swabs are used 
to collect samples from both eyes of the subject. The swabs are then directly inserted into sterile 
RPMI culture media and sealed on ice for transport. The culture media is immediately plated 
onto blood agar plate upon arrival of a certified biological hood.  
3.3 Results & Discussion: 
Our artificial cornea prototype was successfully implanted into the eyes of two rabbits. 
The femtosecond laser incision allowed for better initial apposition of epithelium to the implant. 
However, in both animals, there was a gap between the central optic edge and the cornea that 
increased over the one-month period. Neovascularization occurred into the gap between implant 
and lamellar pocket. There were no instances of infection. There were no instances of extrusion. 
SEM images showed gross preservation of the nanostructures on the central optic. No microbial 
growth was observed in cultures from either the eye with the implant or control eye.  
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Figure 3.2 Slit Lamp (Top) and AS-OCT (Bottom) of the Implanted Rabbit Eye Before and After One Month Period 
 
Both rabbits survived their one-month implants, under healthy conditions, with no sign of 
extrusion nor outstanding infections. Although both subjects were in healthy conditions, the 
study was terminated at early onset. The duration when a normal cornea transplant could be 
functioning in the eye was traded off for the nanopattern’s examination on the device. In situ 
quality control for nanopatterns is difficult to obtain, and to gather more evidence from a device 
durability perspective is be beneficial at the early development stage. Therefore, in the future 
studies, the prototypes could potentially be tolerated longer in vivo, paving the way to a more 
comprehensive and informative cohort. 
As shown in the explanted device’s micrographs in quality control, the device maintains 
in good conditions, with nanotopography withstanding the prolonged period of blinking shear. 
Although some instances of protein deposition on the surface were observed, majority of the 
surface pertained visible nanostructures. This provides evidence to support the hypothesis that 
nanotopographic motifs are resilient enough in complex physiological environments, expanding 
4 weeks 
Recession of 
epithelium 
Neovascularization 
Initial 
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the possibility of translating this in other challenging conditions such as cardiovascular or 
pulmonary replacements. 
 
Figure 3.3 Scanning Electron Micrographs Indicates Nanopatterns Retain High Fidelity After One-Month Implant 
3.4 Crucial Lessons & Future Directions 
The confirmation of the nanotopographic modification could survive and sustain in the 
harsh environment in the eye, specific address the high shear and frequent eyelid brushing.  
The hypothesized long-term protein deposition is also less influential on the surface 
presence than previous considered. This gives optimistic outlook for the extending coverage of 
materials with nanotopography.  
The recession of epithelium slowly developed during the pilot trial, which is a sub-
optimal clinical outcome. However, the next-step integration of nanoline on the skirt is intended 
to mitigate the issue. The future trial shall implement the complete nanostructure control to 
emphasize tissue healing and device integration in animal.  
Overall experimental method could be standardized and selectively modified for future 
use, especially the fixation and in vivo modalities. However, improvement on the bacterial test 
should be suggested. Gathering more adjacent facility and resources to allow on-site plating and 
culturing to avoid long distance and freezing cycle would eliminate the false positive of 
antibacterial effect and provide more insightful data. 
Prior to implantation After explantation 
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Per surgeon’s operational feedback, device’s flexibility during surgery is desirable. The 
more elastic and durable polyurethane-based prototype shall be scheduled for ex vivo and 
possibly in vivo test in the future.  
Chapter 4: Fabrication of contact lens for antifungal property with nanotopography 
4.1 Motivation 
In the upcoming chapters, another ophthalmic product, a bandage contact lens for fungal 
keratitis, closely spinning off from the development will be detailed. This product’s production 
share similar challenges as previously seen in artificial cornea device, such as the nanopattern 
transfer onto spherical surfaces. Furthermore, the contact lens manufacturing is proven to have 
its unique challenges. These challenges underlie in the call for a new hydrogel that not only 
carries therapeutics, but also advance its effect, but remain mechanically durable and easily 
manufacturable. Upon preliminary research, chitosan is considered to be a potential candidate 
that can fulfill all the demands with minor modification or additives. In this following chapter, 
additives that initiate crosslinking or modify substrates to grant crosslinking ability are 
discussed.  
4.2 Proposed Nanopattern lens fabrication material system: PU/Chitosan 
Chitosan is a natural polysaccharide commonly found in shrimp and crab shells. It’s a 
deacetylated derivative of another natural polysaccharide chitin. Chitosan is soluble in strongly 
acidic environment via the mechanism of protonation of amino side groups. Both chitin and 
chitosan process good mechanical strength in the dry stage, such as young’s modulus and tensile 
strength. Chitosan also could be processed into a biocompatible hydrogel upon different 
processing. It has a high glass transition and decomposition temperature and optical 
transparency.25 
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Both polyurethane and chitosan exhibit excellent mechanical properties favorable in a 
commercially viable product. Polyurethane, commercially widely tuned and implemented, offers 
a huge variety of modulus and processing possibilities, by simply selectively tune the ratio of the 
synthesized blocks. Polyurethane is resistant to a good collection of common organic solvents, 
except for DMF, used to process this material primarily here.  
Chitosan as a natural biological macromolecule, carries excellent range of mechanical 
strength adjustable per demand of the application. It’s resistant to most organic solvents and 
soluble in acidic aqueous solution. Unlike other commercial polymers, chitosan’s glass transition 
temperature is comparatively higher.  
The mutual exclusivity of the solvent systems used to process polyurethane and chitosan 
respectively and large different between their glass transition temperatures gives rise to a mean 
to choose selectively of one of the two in the interfacing combination. The compounded system 
as a whole is also resilient enough to go through conventional heated and pressurized molding 
and forming method. Specifically, in our case, when chitosan is cast onto a nanopatterned PU 
mold and it undergo a lens forming process together, the nanopattern replicated from the casting 
method onto chitosan will not altered while PU undergo glass transition and adapt the bulk 
curvature. Afterwards, the PU will be in the lens shape with the nanopatterns protected by the 
chitosan layer. With either simple peeling or soaking of the double layer in acidic solution, the 
system could be separated.  
 
Figure 4.1 SEM of Assorted Chitosan-based Nanopattern and PMMA replica as quality control 
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4.3 Crosslinking Strategy for Chitosan 4.3.1	Additive	Crosslinking	as	molding	strategy:	TPP	and	Glutaldehyde	with	chitosan	
Sodium triphosphate is a commonly used physical crosslinker of chitosan. We tested 
various concentration (0.1%, 1%, 5% 10% wt) of TPP for producing crosslinked chitosan with 
nanostructures that withstand substantial swelling in aqueous environment. Currently, using TPP 
solution of 0.1% wt, 20 mL in volume, to submerge for 30 mins and crosslink patterned chitosan 
films is the best formula. This product could withstand 48 hours of swelling without the loss of 
nanotopography. The quantitative height of such surface is still to be determined by AFM, but 
SEM images suggest non-significant reduction of the structure’s height.  
Glutaldehyde is a common chemical crosslinker for chitosan, and widely used for 
biological sample fixation. Similarly to TPP, we tested a range of concentration (0.25%, 0.5%, 
2.5%) of Glutaldehyde solution to produce chitosan films with submersion. Although films with 
nanostructures could be produced, preliminary testing suggests that the structures might not have 
survived water swelling for over a day. Further evaluation is needed with submersion method.   
Glutaldehyde is also attempted to be blended into chitosan solution prior to casting or 
molding process at various concentration (0.25%, 0.32%, 0.5%, 2.5% wt) to control the set time 
of the system. In preliminary tests, at or above theoretical critical crosslinking concentration of 
0.32%, solutions reach to complete gelation stage with increasing degrees of yellowing.  
 4.3.2	UV-Crosslinkable	N-MAC	is	a	suitable	candidate	for	a	bandage	contact	lens	prototype	
To further diversity the toolbox of crosslinking and defining the contact lens, the 
modification of chitosan to grant externally controlled crosslinking activation is explored. N-
MAC’s is a key adoption driver for contact lens prototype. Previous literatures have various 
recipes of using different triggers to initiate the crosslinking. The light, specifically UV light 
activation, is studied with the consideration of future industrial adaptability and 
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manufacturability. Currently, contact lens manufacturers have broadly utilize pHEMA and 
silicones in lines of products. Both of these materials’ curing process are light-initiated, which 
has better engineering control for reproducibility and potential for a shorter processing time. If 
chitosan’s derivatives could mirror a majority of those materials, future technological acquisition 
by existing companies would be smoother with less resistance on their finance and 
infrastructures.   
Among scores of recipes from previous literature, the following modification scheme 
stands out for the following particular reasons: 1.  The modification scheme is short and involves 
only one chemical, reducing the intensity of advance chemical purification and characterizations. 
2. The modification scheme has high specificity and utilize a preferable substitution mechanism, 
making the yield of the final product higher. 3. The modification involves little highly toxic 
chemical, addressing the concern of both toxicity of the final product and the currently conscious 
principle of greener chemistry.  
 
Figure 4.2 N-MAC Synthesis Mechanism: the functional amine group on the deacylated chitosan is attached by one 
branch of the methacrylate anhydride. The additional substituent carries the double bond required to be UV-
activated on demand by radically excited initiators.26 
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Synthesis: 
1% chitosan in 0.1 M acidic acid solution is prepared by gently stirring chitosan powder 
into the acidic mix for 4-6 hrs at low speed. After the full dissolution, methacrylate anhydride 
(MA) are added slowly into the solution. The amount of MA is determined by the ratio of 
anhydride to amino group. The latter used ratio are 4 times of the chitosan’s available amino 
groups, unless specified. The reaction occurs at 60 degree Celsius for 6 hours. The reacted 
solution will be transferred to dialysis tube with 11-14 k cut-off threshold. The dialysis will be 
performed against DI water to remove excess MA and acid, for 4 days with replenishment of DI 
water reservoir every 24 hours. Afterwards, purified solution will be lyophilized for 24 hours to 
remove all water. The extracts should be snow white sponge-like aggregate. This could 
reconstitute in neutral purified water overnight. 
 
Figure 4.3 Synthetic Workflow Schematics of N-MAC 
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Material Characterization: 
Dried thin film of modified NMAC is characterized using FTIR to locate the 
modification on the biomolecule. Unmodified chitosan film is used as a control, labeled in black 
in the figure below. Focusing at the region of 1000-2000 cm-1 wavenumber, amide related peaks 
are accentuated at three specific wavenumbers of 1315, 1536, 1654(amide c=o strentch) cm-1. 
The additional amides detected in the spectrum represent the successful modification of the 
chitosan’s amine group with methacrylic group, enabling the molecule’s photocrosslinking 
capability. Within the 1000-1800 range, a few other peaks that are potentially representing 
Alkenyl C=C Stretch (1680-1620 cm-1) also more substantial in the modified NMAC than the 
regular chitosan. Furthermore, to confirm that our purification process is effective, no c=o 
anhydride bonds is detected in the adjacency of 1800 cm-1, representing the exclusion of 
methacrylic anhydride (MA)’s presence in the film.  
 
 
Figure 4.4 FTIR Spectrum of N-MAC showing the addition and alteration of amine group and double bonds 
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Swelling Behavior: 
UV-crosslinked N-MAC hydrogel is also evaluated for its swelling and drying behavior 
with water to gauge the impact of the physiological environment on the release of potential 
therapeutic payloads based on its fabrication exposure process.  
The hydrogel is crosslinked with a deposit of 80 μL of 1wt% N-MAC solution in MilliQ 
water on a mold of a PDMS artificial cornea mold for different duration (5/15/30 mins), at the 
50% relative maximum exposure power. The swelling sample is submerged MilliQ water in a 
closed well plate and the drying sample is left in opened well plate to air dry. The weight of the 
samples is measured hourly for short-term study and every 8 hours for 24 hours in long term 
group.  
The figure below shows the sample’s relative change of water content in percentage. 
Among three different exposing protocol, all N-MAC exhibits maximum water intake in 
approximately the same period of around 1.5 hours and start to reduce weight in a consistent 
manner, while drying rate reaches plateau differently but yield the same remnant mass. The 15 
mins crosslinking exposure show distinguishing behaviors while experiencing gaining and losing 
water in the hydrogel. The 15-min hydrogel intake significantly 40% less water contents than the 
other two exposure length. Its drying pattern reaches the deflecting point of 2.2 hours, earlier 
than 5- and 30-min samples. These two trends suggest that an optimal time point exists around 
15 mins for minimal water intake.  
Under a given modification ratio, there will be a sufficient amount of radiation that could 
result in the vast majority of the crosslinkable C=C double bonds to be thoroughly reacted. Lack 
of exposure could leave some of the viable sites unused that forms a looser material network that 
enable more expansion and water infiltration. Overexposure of strong UV radiation, on the other 
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hand, may have introduced cleavage of polymeric chains that reduce network connectivity, 
leading to high swelling ratio.  
 
Figure 4.5 Consistent  Swelling and Drying Behavior of N-MAC under Various Crosslinking Exposure Time 
The figure below shows the light absorption of chitosan and derivative products across 
the 300-750 nm spectrum, covering the 400-700 nm visible light range. Samples measured are 
prepared by dispensing 10 μL of each type of sample into a well on 96-well plate for 
standardized UV-Vis measurement. The volume and the thickness used for measurement is 
consistent with the murine lens fabrication. Within the visible spectrum, all samples, either 
modified or non-modified chitosan sample, record less than 4% absorption of light, considered to 
be exceptionally above the standard requirement in the contact lens industry, where acceptable 
commercial lens products generally record less than 10% loss from the light source.   
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Figure 4.6 UV-Vis Absorption Spectrum of the Crosslinked N-MAC Shows Minimal Absorption of Visible Lights 
N-MAC posess more capability as a nanopattern carrier material than commercial 
pHEMA. In the rise of the question where some hydrogels, such as pHEMA, present high 
surface tension during swelling process that could smoothen and erase the implemented 
nanopatterns, the new N-MAC needs to be tested for its capability to retain nanotopographic 
surface modification during potential swelling during fabrication and storage of the lens 
production.  
N-MAC hydrogel Crosslinking Protocol:  
In brief, 10 μL of 1wt% N-MAC solution is pipetted onto the P500 polyurethane mold 
and cured for 5-10 mins until gelation. The hydrogel is fixed a serially dehydrated with 2.5% 
glutaraldehyde and 50-100% ethanol solution. The gel is then detached and prepared for SEM. 
Following crosslinking protocol, fixing and dehydration process, a N-MAC film is 
nanopatterned via a PU nanopattern mold and imaged in dry condition under SEM. The P500 
nanopatterns are replicated faithfully and retained at the surface of the hydrogel, shown in the 
representative SEM image below.  
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Figure 4.7 Nanopatterned N-MAC Gel Surface Has Good Fidelity of the Reverse Replication 
The presented SEM has shown reverse replication of the nanopattern of p500 pillars in 
good fidelity, where the close-packed configuration and the periodicity are closely resembling its 
master. The height of the pillars is less consistently measured by AFM, possible for the nature 
low elastic modulus of the hydrogel. This sample is also measured after dehydration process to 
accommodate the high vacuum environment for SEM operation. It’s possible that some of the 
crosslinking effect taken place in the same is contributed by the post processing fixative, rather 
than modified hydrogel’s photo-initiated crosslinking alone. This hypothesis could be validated 
in the future with the availability of an environmental SEM at lower vacuum level or a liquid 
AFM that scans humidified samples. Despite the limitation of characterization technique, this 
sample provide insights that the photocrosslinking chitosan could be more enduring as a 
nanopattern carrier than commercially prevalent pHEMA, which is essential to materialize the 
proposed integration of nanopatterns on a softer class of polymeric material.  
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4.4 Conclusion:  
The results prove that biocompatibility and toxicity shall be included and even prioritize 
in the consideration of modification of biomaterials, such as N-MAC, that will be implemented 
into clinical application. Moreover, the functional demands such as mechanical constrains, 
dimensions, fabrication endurance, and specifically in this instance, the optical clarity and 
coloring, is vital for a clinically translatable product.   
Chapter 5 Mouse and Rabbit model for antifungal efficacy test 
5.1 Motivation 
Although rodent models are popular in vivo platform to in the study of ophthalmology, 
researcher has limited access to customized murine fitted contact lens at a high cost. Researcher 
currently deploy strategies such as performing eyelid closure surgery or settle for equivalent in 
vitro cell culture models instead. Such compromises made for the lack of easy access to 
convenient better fitted manufacturing scheme are hindersome to produce relevant results for 
ocular pharmaceutical products. The technical challenge of fabricating murine lens rooted at the 
steep curvature of the natural mouse eye. Previous literature provided example measurements of 
6 weeks old C57BL/6 mice indicated a corneal diameter of 3.2 mm and SAG (Sagittal Depth) of 
1.5 mm and lens thickness are generally ~20% of its average diameter (0.6 mm).18 Although 
previous works occasionally show the possibility of making fitted lens in lab, such lens currently 
requires specialty machines and skilled technicians to produce, limiting the quantity and access 
to the scientific community at large. For more reproducible and statistically analyzable data set, a 
scalable and widely distributable method is essential to advance eyecare solutions.  
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In this chapter, a simple, and scalable molding method to produce murine fitted contact 
lens is discussed. The recipe tackles the challenging dimension problem with popular lab 
supplies at an affordable price range, in hope of expanding researchers’ capability to arrange 
larger animal cohort in the future.  
  
Figure 5.1 Representative images of a murine cornea after wearing a P. aeruginosa-inoculated CL for 22 days 
without the development of bacterial keratitis. Dissecting microscope image (left) and confocal image (right) 18 
5.2 Murine Model Contact Lens Fabrication Protocol 
Murine fitted lens mold is molded following the procedure illustrated below. 3mm glass 
beads coated with Teflon or other anti-adhesives are used as the model of a murine eye. A thin 
supportive layer (1-1.5 g) of PDMS is first cured at the bottom of a detachable cup. After 2 hours 
of solidification, a thin spread (~0.5 g) of PDMS is added on top of the cured layer. Glass beads 
is then carefully placed in the container and the mold is baked again for 2 hours at 110 C. After 
curing, the glass beads are twisted and discarded. 
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Figure 5.2 Fabrication of murine lens mold and molding mouse lens with two chitosan-based hydrogels 
 
For a 3-mm diameter chitosan-TPP lens, 10-15 μL of the 2% chitosan solution is pipetted in 
a lens mold, and air dried at room temperature for 4 hours. The lens is carefully lifted and 
detached from the mold. The lens is crosslinked by 10wt% NaOH for 1 minute and followed by 
0.1wt% TPP solution for 5 minutes. The crosslinked lens is then submerged into PBS for storage 
at room temperature.  
For gelation of a 3-mm diameter lens, 5 or 10 μL of the 1% N-MAC photocrosslinkable 
chitosan solution is pipetted in a lens mold, and a 3-mm glass bead is placed onto the drop. The 
assembly is exposed to UV lamp at its 50% relative intensity, 5 mm away from the leading probe 
tip. The lens is carefully lifted and detached from the mold and the bead and submerged into PBS 
for storage at room temperature. Figure D-JC demonstrate the product’s clear and highly 
spherical resemblance to a murine contact lens.  
 
 
 
Figure 5.3 Murine lens of N-MAC under stereomicroscope, bottom-up view (left) and side view (right) 
1mm 
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5.3 Lens In Vivo Fitting Results 
Previously described mouse fitted lens are tested for the mouse’s wearing comfort and 
compliances. The fabricated prototypes are sterilized with UV lamp in biohood and/or 
extensively washed with sterile PBS solution before animal use. The lens is fitted to the 
anesthetized mice with surgical tweezers under optical microscope. Mice are left to recover and 
resume normal activity after operation. Images of the mouse eyes wearing the Chitosan-TPP 
contact lens are shown at two different focal point. The lenses adhere well with only one single 
lens falling out of 5 pairs lens tested after 1 day.  
 
Figure 5.4 Murine lens of Chitosan-TPP fitted under microscope, initial time point view (top) and after one day 
(right) 
5.4 Further Work 
To investigate further about the fitness of the lens on the cornea, Anterior segmented 
optical coherent tomography could be used to visualize the cross-sectional profile of the nearby 
of the cornea. AS-OCT is more prevalent for larger animal model such as rabbits and human 
while murine specific AS-OCT is not widely commercially available but potential academic 
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contacts within centralized ophthalmological research institute could provide adapting guidance. 
Live Fluorescent microscopy similar Matteo et al. used above would also be informative to 
visualize underlying tissue’s recovery and potentially the fungal activity in tandem. Future 
monitoring of the mouse behavior will be improved by adding in-cage surveillance camera for 
continuous discomfort monitoring and timely response to other urgent situation possibly caused 
by infections. 
5.5 Potential vessel for constructing a Fungal Infection Induction Model  
The mouse fitting contact lens could not only realize the sustain delivery of the drug for 
the proposed therapeutic standpoint, but also could be applied for a pathology study angle where 
the pathogen contaminated lens appears in daily use could be quantitatively mimicked. A brief 
illustration below demonstrates the application of the proposal. This proposed model would be 
advantageous for studying what is the public health implication of the popular non-sterile 
consumer habit.  
 
Figure 5.5 Illustration to Apply Fungal Infection Induction Model 
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Chapter 6: Vacuum Assembly for Tunable Lens Fabrication  
6.1 Motivation 
 Tunable and larger lens for other model’s fitted lens fabrication such as rabbits would be 
demanded in the near future to advance preclinical validation. To adjust to the model’s 
dimension appropriately, machinery for variable and reliable fabrication is needed. In this half of 
the chapter, an assembly is sketched out to incorporate those in lab production needs, primarily 
on achieving the proper curvature.  
6.2 Materials and Method 
The system is enabled by the previously mentioned polyurethane (PU) nanopattern mold. 
(chapter 2) The flexible nature of the thin PU mold could conform onto the supportive assembly 
structure under uniform pressure application. Such pressure is delivered by using vacuuming. 
Negative air pressure could avoid local and concentrated solid contacts that damage nanopattern 
molds. The uniformity of air pressure is also desirable to prevent the thin mold folds or wrinkles 
instead of expansively conforms onto molds. Smooth finishing is crucial for contact lenses for 
both wearing comforts and optical clarity.  
 
Figure 6.1 Mechanistic Illustration of Vacuum Lens Fabrication Assembly 
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 The assembly comes in two parts, inspired by the previous work used for reversal 
imprinting.21 The top plunger is designed to secure the mold’s position with the alignment pins 
and seal off air leakage from the thin film’s fringes. The cover could also avoid particle falling 
off during productions, should it occur. The dome-shaped base contains the customizable 
spherical supportive structure visible from the top-down view, centered in the 22x22 mm squared 
slot that tightly fit the thin PU mold cast from standard nanopattern masters. A small through 
hole connecting from the bottom of the lens to the bottom of the assembly, allowing negative air 
pressure to convey through. The ring surrounding the hole for easy insertion for tubing.  
The assembly is intended to be 3D printed and polished with metals such as aluminum, 
steels or coppers. The 3D printing method, especially for the dome-shaped base, is convenient to 
switch the supporting curvature, accordingly to clinical measurement such as OCT, without 
major change in the prototyping method. The material choice is to provide a mechanically sound 
and heat-conductive environment. Minor heat could expedite the evaporation in drop casting 
processing, allowing faster turnaround time in larger experimental group.  
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6.3 Parts and Expose-Cut Assembly 
 
 
Figure 6.2 Solidwork Rendering of Vacuum Lens Fabrication Assembly (Left: by parts; Right: by Closed Assembly) 
6.4 Generic Protocol for Lens Prototyping with Vacuum Assembly  Part	1:	Fabrication	of	PU	nanopattern	mold	
1.     Dropcast 10wt% 72D in DMF solution on the nickel mold 
2.     Dry on hot plate around 70 ℃ 
3.     Without peeling of the PU film, transfer to tetrahedron, use two Teflon film for 
sandwiching 
4.     Imprint protocol: 
a.     266℉, 1.0 klbf, 5 mins 
b.     88℉, 1.0 klbs, 5 mins 
5.     Remove Film from mold as negative mold Part	2:	Assembly	in	vacuum	mold	
1. Insert PU negative mold film into the mold hole of the base assembly, pin down by 
alignment pins 
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2. Stabilize the assembly and insert the vacuum tubing in the bottom, turn on suction and 
smoothen out the mold in the spherical dimple gently 
3. Dropcast desired solution (eg. Chitosan) onto the nanopatterned mold and air dry for lens 
prototype (generally takes 2-3 hrs) 
4. After drying, carefully use tweezers to detach the lens from the PU nanopattern mold  
Chapter 7: Commercialization Exploration of Artificial Cornea and Contact Lens 
7.1 I-CORP Experimental Iteration 7.1.1	Motivation	
The customer discovery phase on the entrepreneurial market research intends to survey a 
wide range of industrial stakeholders’ opinion and sentiments. Eventually the project improves 
the presentative message of our product.  7.1.2	Research	Method		
Weekly, 10 interviews of 10-15 mins with directly involved personnel are arranged.  
Participants include ophthalmologist, corneal specialist, registered nurses, eye-care corporate 
marketeers, academic professors, and venture capitalists and patent attorneys. Questionnaires are 
curated customarily.  Note and transcriptions are prepared afterwards for analysis. Project pitch 
is edited at the end of each week after integrating useful input from fellow project trainees and 
interviewees. Four iterations, 42 participants are recruited during the one-month refining period.  
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7.1.3	Results	
Table 2: Value Proposition Progression 
1st Proposition The NanoCurv is an artificial cornea marketed for ophthalmologists 
located at hospitals and eye care centers in the US that will decrease 
postoperative complications and eliminate patient reliance on eyedrops. 
Revision 
Comment 
For statement clarity for pitching, suggested to consolidate the initial 
proposition and reduce use of medical jargons. 
2nd Proposition Our corneal replacement restores patients’ sight for longer than a donor 
cornea by reducing the likelihood of complications and rejection. 
Revision 
Comment 
Narrow down more responsive key features. 
3rd Proposition NanoCurv is an artificial cornea that could help patients recover faster by 
decreasing the rejection rate, providing more customized vision and 
reduce long term steroidal drop use. For medical device companies, the 
device has longer shelf life and easier storage at a lower cost. 
Revision 
Comment 
Research further towards relating indications/medical issue onto part(s) 
of the product’s value proposition 
4th Proposition NanoCurv is an artificial cornea that could help patients recover faster by 
decreasing the rejection and infection rate, providing more customized 
visual outcome and reduce long term steroidal drop use. For medical 
device companies, the device has longer shelf life and easier storage at a 
lower cost. Especially in urgent cases such as warzones and chemical 
attack, the device provides instant accessibility under insurgence. 
 
Table 3: Target Customers 
1st Proposition Ophthalmologists/Eye Care Center Admin/Hospital Admin 
Revision 
Comment 
The popular surgical occurring sites are eye clinics and dedicated 
ophthalmic institutes instead of general hospitals. Suggested to remove 
Hospital admin from the list for specificity.  
2nd Proposition Ophthalmologists/Eye Care Center Admin 
Revision 
Comment 
Be more specific and tailor values onto targeted customer segments 
3rd Proposition U.S. ophthalmologist and patients relevant to full thickness replacement, 
and corresponding eye care centers admins for logistics. 
Revision 
Comment 
Further define customers in more marketable details. 
4th Proposition U.S. Ophthalmologist/US full thickness replacement patients with 
previous graft failure or keratoconus. For institutions, high volume U.S. 
Eye centers are primary targets. 
 
		 42 
7.1.4	Discussion	and	Future	Work	
 Customer discovery process is greatly beneficial to both the product as well as the 
development team to understand the medical, societal and financial problem an artificial cornea 
device is addressing. We recognize that our domestic needs are relatively niche and mature while 
oversea demands are more attractive financially and logistically complex at the moment. For the 
project development at current stage, the team and future potential cooperation entity would be 
advice to approach domestic partnerships for funding, and dedicated networks of distribution to 
gain overseas interests and negotiate international partnerships with the established templates 
used in the United States.  
 With the latest waves of interests to encourage biomedical entrepreneurship, a collection 
of competitions and initiatives are available for not only seed funding, but also connection to 
venture capitalists and wider range of medical professionals in the field.  
 
7.2 New Venture Competition (NVC) 
In continuum of the effort to explore the commercial viability of the NanoCurv artificial 
cornea, the New Venture Competition (NVC) is served as a suitable testing ground prior to the 
product’s official move into its corporation goal. Not only does NVC introduces universally 
accepted formats to formulate a future pitch for products and company development, but also 
acts as a platform to connect both local and international partners to us via showcasing. The 
competition’s success will entitle the project with small amount of financial support and 
publicity in the ophthalmic field for further attracts institutional support and capitals. 
The participating in the competition yields two primary deliverables: 1. The concept 
paper, a short booklet with rich but summative illustrative facts and analysis to draw in initial 
interests of investors and judges. 2. The pitch desk, a 12-minute scripted presentation for more 
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detailed pitching events to advance our product’s story and imagery and cover logistics details to 
ground investors into negotiation track. 
In the process of producing aforementioned product, both academic and business research are 
advances. Particularly, in terms of business research, market analysis, competitors, and business 
models are crucial segments to cover in both documents. A few essential takeaways are below: 
1. For the U.S. domestic niche market for cornea transplant has relatively maturity and self-
sustainability, global presence and international partnership would be crucial to reach to 
patients in needs. 
2. However, direct sales with global presence across continentals requires large amount of 
capital and long period for customers and regulatory relations. Drafting partnership 
agreement with well-established eyecare corporate such as Alcon and CorneaGen could 
fast track product distribution and approvals.  
3. Conservatively, to roll out the proposed model, roughly $5 million will need to be raised 
in the first 2 years to cover R&D expenses and partnership legal proceedings, until the 
first sales of products.  
 
 
 
Figure 7.1. Schematics of revenue streams in the proposed licensing business model for global expansion. 
		 44 
 
 
Figure 7.2 Total available market (TAM, in large circles) and Serviceable Obtainable Market (SOM, in raindrops) 
of potential regions around the globe. Projected business advancement timeline is also listed below in maps. With 
licensing model, the combine of both product line internationally could generate an estimate revenue of $16.4 M. 
Credit: Wyobroski and Cai 
Chapter 8. Future Outlooks 
 Looking ahead, medical solutions for corneal disease have a bright future. Besides 
propelling further with validating and commercializing efforts for our ophthalmic projects, we 
should also stay updated and connected with other researchers in the field. Representatives in 
four categories are covered for future references and possible collaborative talk.  
1. From the aspect of using wound healing promoting biomaterials, Massachusetts Eye and 
Eye Infirmary’s researcher Dr. Dana Reza utilizes similar decoration scheme as the N-
MAC modification mentioned in Chapter 4, on gelatin, another popular biomaterial. 
Chitosan could potentially have additional antimicrobial effect, compared to the gelatin 
derivative GelCore, but lacks the easy processing gelatin molecules are. 27 
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2. Taking advantages of a complete acellular material approach, recent attentions were 
drawn to Gore-Tex by W.L. Gore, a long time Teflon experienced cooporation by 
Bloomberg. Although short of academic publication, the disclosed timeline for the 
company is comparable to our project’s stage. Teflon has been the platform for many 
medical application for its strong non-adhesive surface property. Nanopattern as a 
versatile tool to tune surface property, could possibly applied in more materials than ones 
covered in the limited thesis. 28 
3. From a regenerative medicine perspective, Dr. Nishida’s lab has strengthened corneal 
stem cell’s understanding. 29 More stable differentiation methods on corneal stem cells 
could provide the cellular components our product is trying to better interface with. 
Furthermore, Dr. Evelyn Yim’s lab paths on specifically useful insights of nanopatterns 
and stem cell. 30 
 
In sum, with our unique expertise, extending our materials and fabrication methods as a 
platform and reach over to cellular and molecular control to create the comprehensive 
treatment option would be promising.  				
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